Verismo Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product (NCT06701201) | Verismo Therapeutics | 2025-01-27 |
| SynKIR-310 for Relapsed/Refractory B-NHL (NCT06544265) | Verismo Therapeutics | 2024-11-01 |
| Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies (NCT06377202) | Verismo Therapeutics | 2023-11-15 |
| SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma (NCT05568680) | Verismo Therapeutics | 2023-03-30 |
Track Verismo Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.